Our Products

Wegovy (semaglutide)

Wegovy is a prescription medication containing the active ingredient semaglutide. It is approved for chronic weight management in adults with obesity or overweight who have at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol). It works by mimicking a hormone that targets areas of the brain involved in appetite regulation, helping you feel fuller and eat less.

Key Use: Weight management.
Important Safety Information: May cause side effects like nausea, diarrhea, vomiting, and constipation. Serious side effects can include pancreatitis, gallbladder problems, and kidney problems. Tell your doctor about any personal or family history of thyroid cancer.

Ozempic (semaglutide)

Ozempic is a once-weekly injection for adults with type 2 diabetes. It improves blood sugar levels and has also demonstrated significant cardiovascular benefits. It works by helping your body produce more insulin when needed and lowering the amount of sugar released by your liver.

Key Use: Improve blood sugar in type 2 diabetes, with cardiovascular risk reduction.
Important Safety Information: Do not use if you have a personal or family history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Risk of thyroid C-cell tumors. Monitor for pancreatitis.

Saxenda (liraglutide)

Saxenda is a daily injectable prescription medication for weight management. It is designed for adults with a high BMI or those with weight-related medical problems. It acts like a hormone called GLP-1 that helps regulate appetite and food intake.

Key Use: Weight management.
Important Safety Information: Has a boxed warning for thyroid C-cell tumors in rodents; it is unknown if it causes them in humans. Do not use with other GLP-1 receptor agonists. Common side effects include nausea, headache, and diarrhea.

Mounjaro (tirzepatide)

Mounjaro is a novel, once-weekly injection that combines two mechanisms (GIP and GLP-1 receptor agonism) to improve blood sugar control in adults with type 2 diabetes. It has also been highly effective for weight loss in clinical trials.

Key Use: Improve blood sugar in type 2 diabetes; also used for weight management.
Important Safety Information: May cause severe stomach issues. Do not use if you have a personal or family history of MTC or MEN 2. Risk of thyroid tumors. Monitor for pancreatitis and vision changes.

Zepbound (tirzepatide)

Zepbound contains the same active ingredient as Mounjaro (tirzepatide) but is specifically approved for chronic weight management in adults with obesity or who are overweight with at least one weight-related condition. It is a powerful once-weekly injection that targets multiple pathways to reduce appetite and increase satiety.

Key Use: Weight management.
Important Safety Information: The same safety profile as Mounjaro. Contraindicated in patients with a personal or family history of MTC or MEN 2. Warns of thyroid C-cell tumors, pancreatitis, and severe gastrointestinal disease.